Enzo Biochem completes merger with Bethpage Parent; stockholders to receive $0.70/share

ENZO BIOCHEM INC

Merger closed August 20, 2025; each share converted to $0.70 cash per the Merger Agreement.
Shares ceased trading on OTCQX; company to file Form 15 to deregister and suspend SEC reporting.
Directors Pully, Radoff, Couchman, and Cannon resigned at the effective time.
Certificate of incorporation and bylaws were amended and restated in connection with the merger.

item 2.01item 1.01item 3.01item 3.03item 5.03item 5.01item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.